Polar Asset Management Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $548K | Buy |
+159,800
| New | +$548K | 0.01% | 372 |
|
|
2025
Q1 | – | Sell |
-117,830
| Closed | -$345K | – | 481 |
|
|
2024
Q4 | $345K | Hold |
117,830
| – | – | ﹤0.01% | 444 |
|
|
2024
Q3 | $306K | Hold |
117,830
| – | – | 0.01% | 457 |
|
|
2024
Q2 | $349K | Hold |
117,830
| – | – | 0.01% | 419 |
|
|
2024
Q1 | $534K | Hold |
117,830
| – | – | 0.01% | 444 |
|
|
2023
Q4 | $673K | Hold |
117,830
| – | – | 0.01% | 419 |
|
|
2023
Q3 | $542K | Hold |
117,830
| – | – | 0.01% | 472 |
|
|
2023
Q2 | $761K | Hold |
117,830
| – | – | 0.01% | 517 |
|
|
2023
Q1 | $888K | Hold |
117,830
| – | – | 0.01% | 541 |
|
|
2022
Q4 | $1.19M | Hold |
117,830
| – | – | 0.01% | 617 |
|
|
2022
Q3 | $1.17M | Hold |
117,830
| – | – | 0.01% | 702 |
|
|
2022
Q2 | $1.26M | Sell |
117,830
-510,300
| -81% | -$5.44M | 0.01% | 688 |
|
|
2022
Q1 | $6.12M | Buy |
+628,130
| New | +$6.12M | 0.07% | 336 |
|
|
2021
Q4 | – | Sell |
-25,000
| Closed | -$501K | – | 1238 |
|
|
2021
Q3 | $501K | Sell |
25,000
-30,000
| -55% | -$601K | ﹤0.01% | 769 |
|
|
2021
Q2 | $1.21M | Buy |
55,000
+15,000
| +38% | +$330K | 0.01% | 550 |
|
|
2021
Q1 | $1.36M | Sell |
40,000
-135,000
| -77% | -$4.58M | 0.01% | 466 |
|
|
2020
Q4 | $7.04M | Buy |
+175,000
| New | +$7.04M | 0.08% | 207 |
|